Gainers:
Schiff Nutrition International Inc. (SHF) gained nearly 30 percent to $43.99 following the news that Reckitt Benckiser Group PLC (RB.L) has offered to acquire the company for $42.00 per share in cash. Recently, Bayer has agreed to buy Schiff for $34.00 per share.
Gap Inc. (GPS) gained over 3 percent to $34.31. The company's third quarter profit surged 60 percent from the previous year period. Net sales increased 8 percent and managed to beat the consensus estimate. The company also raised its earnings per share forecast for fiscal year 2012.
Decliners:
Dell Inc. (DELL) fell more than 2 percent to $9.30. The company's third quarter earnings declined 47 percent from the year-ago quarter and its adjusted earnings per share were below Wall Street view. Revenues for the quarter declined 11 percent as desktop and mobility revenue contracted and also missed the consensus estimate. Dell said it sees the challenging global macro-economic environment continuing in the fourth quarter, which will continue to impact its results.
Sears Holdings Corp. (SHLD) fell 6 percent to $55.00. The company's third quarter net loss widened as sales declined from the same period a year earlier. Domestic comparable store sales declined 3.1 percent, comprised of declines of 1.6 percent at Sears Domestic and 4.8 percent at Kmart.
SINA Corp. (SINA) declined over 6 percent to $49.70. The company swung to a profit in its third quarter. Non-GAAP net income declined from the prior year quarter, but was above Wall Street view. Net revenues improved from the year-ago quarter and were above the consensus estimate. Non-GAAP advertising gross margin declined from the year-ago quarter, mainly due to increased content spending, particularly related to the Olympics, as well as production-related labor and infrastructure costs. Meanwhile, the company forecast non-GAAP net revenues for the fourth quarter below analysts' estimate.
Dynavax Technologies Corp. (DVAX) plunged 62 percent to $1.75 based on the news that the FDA committee voted eight to five with one abstention that there was insufficient data to adequately support the safety of Heplisav, an investigational adult hepatitis B vaccine. Meanwhile, the panel voted 13 to one that Heplisav data adequately demonstrated immunogenicity.
Trading halt:
Trading in shares of Penn National Gaming Inc. (PENN) was halted. The company announced that it intends to pursue a plan to separate its gaming operating assets and real property assets into two publicly traded companies.
For comments and feedback: editorial@rttnews.com